As overall inhibition in IL-6 during the repair phase has been demonstrated to disturb and delay fracture healing (56, 57), the observed reduction of IL-6 in high glucose conditions could, therefore, also contribute to the delay in bone healing associated with T2DM. Here, IL6 is linked to type 2 diabetes mellitus.